Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 1,449 | 2,046 | 1,407 | 1,095 | 983 |
| Cost of Goods | 1,189 | 1,389 | 1,269 | 1,028 | 826 |
| Gross Profit | 260 | 657 | 138 | 67 | 157 |
| Operating Expenses | 10,914 | 12,427 | 15,913 | 17,377 | 23,847 |
| Operating Income | -10,465 | -11,381 | -15,506 | -17,282 | -22,864 |
| Other Income | -194 | -189 | 178 | -1,895 | -274 |
| Pre-tax Income | -10,659 | -11,570 | -15,328 | -19,177 | -23,138 |
| Net Income Continuous | -10,659 | -11,570 | -15,328 | -19,177 | -23,138 |
| Net Income Discontinuous | N/A | -27 | -258 | 583 | -32,181 |
| Net Income | $-10,659 | $-11,597 | $-15,586 | $-18,594 | $-55,319 |
| EPS Basic Total Ops | -0.25 | -0.28 | -0.37 | -0.45 | -1.34 |
| EPS Basic Continuous Ops | -0.25 | -0.27 | -0.37 | -0.46 | -0.56 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | -0.01 | 0.01 | -0.78 |
| EPS Diluted Total Ops | -0.25 | -0.28 | -0.37 | -0.45 | -1.34 |
| EPS Diluted Continuous Ops | -0.25 | -0.27 | -0.37 | -0.46 | -0.56 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | -0.01 | 0.01 | -0.78 |
| EBITDA(a) | $-9,874 | $-10,775 | $-14,930 | $-16,962 | $-21,232 |